If you need to reset your password please enter your email and click the Send button. You will receive an email to complete the process.
Aparicio Rodrigo M, Albi Rodríguez MS. Omalizumab es una opción terapéutica en niños con dermatitis atópica grave resistente a otros tratamientos. Evid Pediatr. 2020;16:19.
You must be registered to perform that action